This website is no longer being updated. Please visit GBCHealth’s new website at: www.gbchealth.org.

BMS Foundation Addresses Growing Diabetes Epidemics in China and India

The Bristol-Myers Squibb Foundation announced a $15 million expansion of its Together on Diabetes initiative to China and India earlier this summer. India and China are both facing fast-growing type 2 diabetes epidemics.  The funded projects will help build healthcare capacity to ensure early diagnosis and treatment of diabetes and pre-diabetes; improve understanding of the epidemics in China and India; develop setting-appropriate diabetes prevention and treatment programs tailored to urban and rural needs; and explore the potential of engaging community health workers in addressing NCDs.

As part of the $15 million infusion into China and India, BMS will give over $700,000 over three years to The Chinese Center for Disease Control  to improve the prevention, diagnosis and treatment of type 2 diabetes in rural areas, where the epidemic‘s growth outpaces that in cities. High medical costs associated with diabetes contributes to poverty in these regions. This program will improve training of local healthcare providers on the village level in Western China to better identify and treat diabetes, build disease awareness and education, as well as mobilize local leaders to prioritize addressing diabetes. Additional BMS funding will go to the Shanghai Charity Foundation to develop a city-focused pilot for diabetes intervention that can then be scaled up in other Chinese cities.

Also part of the program is $1.6 million in grants to four organizations in India to improve diabetes education, awareness, prevention and treatment in both rural and urban settings. The Mamta Health Institute for Mother and Child will run a three-year pilot to assess the use of community health workers in addressing NCDs, with a special focus on type 2 diabetes. The All India Institute of Diabetes and Research and the Swasthya Diabetes Hospital will both create models to improve access to diabetes education, prevention and care that are each tailored to the poor in rural, tribal and urban settings. The Sanjivani Health and Relief Committee will conduct a four-year household study in 348 villages to identify those with pre-diabetes and type 2 diabetes and to improve understanding of the prevalence of type 2 diabetes among rural poor in India.

Learn more about Together on Diabetes in China

Learn more about Together on Diabetes in India